U.S. market Closed. Opens in 1 day 49 minutes

AVXL | Anavex Life Sciences Corp. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-302013-09-302012-09-302011-09-302010-09-302009-09-302008-09-302007-09-302006-09-302005-09-302004-09-30
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/AN/AN/A1.25KN/AN/A12.00KN/A63.11K12.81KN/A75.00K70.00K750.003.00KN/A
Gross ProfitN/AN/AN/AN/AN/AN/AN/A-1.25KN/AN/A-12.00KN/A-63.11K-12.81KN/A-75.00K-70.00K-750.00-3.00KN/A
Operating Expenses55.76M50.99M41.95M30.94M28.81M19.18M15.54M14.88M7.11M2.97M2.13M4.32M6.18M5.64M4.73M5.27M1.58M25.59K91.54K14.47K
Selling, General & Admin12.04M13.07M9.02M5.86M6.85M5.99M5.01M8.33M4.84M2.24M1.87M1.66M3.57M2.91M2.59M3.79M618.22K25.48K91.54KN/A
Research & Development43.72M37.92M32.98M25.23M22.26M13.34M10.67M7.25M2.27M732.39K263.85K2.65M2.60M2.73M2.14M1.48M959.70KN/AN/AN/A
Other Operating ExpensesN/A3.32M-54.10K-149.89K-298.94K1.63M2.02M151.40KN/A199.66K-976.88K1.86K10.36K910.00410.00220.00N/A115.00N/AN/A
Operating Income-55.76M-54.40M-41.92M-30.76M-28.75M-19.18M-15.54M-14.88M-7.11M-2.97M-2.13M-4.32M-6.18M-5.65M-4.73M-5.27M-1.58M-25.59K-91.54K-14.47K
Other Expenses / Income8.26M3.37M4.36M4.83M3.08M2.10M2.28M881.96K-5.00M-8.40M-1.56M-3.98M-1.13M-3.13M-765.49K-81.53K1.24K-56.00125.00N/A
Before Tax Income-47.50M-47.62M-37.64M-26.26M-26.21M-17.38M-13.40M-14.71M-12.11M-11.37M-3.70M-8.16M-7.22M-8.50M-5.44M-5.28M-1.58M-25.53K-91.42KN/A
Income Tax Expenses7.00K358.49K267.56K22.66K82.18K72.75K59.61K29.61K71.83K7.09K51.34K3.99M1.13M3.14M765.49K81.53K3.31KN/A209.0014.39K
Net Income-47.51M-47.98M-37.91M-26.28M-26.29M-17.45M-13.46M-14.74M-12.11M-11.37M-3.70M-8.30M-7.31M-8.78M-5.50M-5.35M-1.58M-25.53K-91.62K-14.39K
Interest Expenses964.00K946.99KN/AN/A151.13KN/AN/A11.32M71.83K7.09K51.34K144.30K90.25K291.83K57.86K11.47K3.31K115.00209.00N/A
Basic Shares Outstanding79.79M76.91M69.80M58.19M48.91M44.66M40.84M35.15M18.58M9.80M7.98M7.04M6.29M5.36M5.05M4.93M4.80M4.80M4.35M1.91M
Diluted Shares Outstanding79.79M76.91M69.80M58.19M48.91M44.66M40.84M35.15M18.58M9.80M7.98M7.04M6.29M5.36M5.05M4.93M4.80M4.80M4.35M1.91M
EBITDA-55.76M-50.94MN/AN/AN/AN/A-15.57M-15.02M-7.11M-2.97M-2.14M-8.06M-6.63M-8.49M-5.44M-5.26M-1.58M-25.42K-91.42K-14.47K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-46.53M-46.67M-37.64M-26.26M-26.06M-17.38M-13.40M-3.39M-11.96M-11.35M-3.60M-4.17M-6.09M-5.35M-4.68M-5.26M-1.57M-25.42K-91.21KN/A
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-302013-09-302012-09-302011-09-302010-09-302009-09-302008-09-302007-09-302006-09-302005-09-302004-09-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙